Hologic
As on 23 May, 2025 | 01:29 IST
| Open | 54.53 |
| Previous Close | 54.82 |
| Beta | 0.10 |
| High | 54.92 |
| Low | 54.15 |
| TTM EPS See historical trend | 4.13(+7.83% YoY) |
| 52 Week High | 84.39 |
| 52 Week Low | 51.98 |
| TTM PE See historical trend | 13.18(Low PE) |
| Mkt. Cap ($ Billion) | 12.78 |
| Dividend Yield | -- |
Advanced Chart
*Delayed by 20 seconds
MC Technicals
| Days | |
|---|---|
| 5 | 55.81 |
| 10 | 56.29 |
| 20 | 56.22 |
| 50 | 58.57 |
| 100 | 63.5 |
| 200 | 71.72 |
Returns
| 1 Week | -2.32% | |
| 1 Month | -6.38% | |
| 3 Months | -15.56% | |
| YTD | -24.42% | |
| 1 Year | -27.22% | |
| 3 Years | -29.97% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| General Electric | 326.81 | 3.61 | 353.75 | 51.23 | 6.38 | 0.47 | 330.40/165.54 | 0.48 | Bullish |
| Abbott | 112.29 | -0.35 | 194.71 | 21.80 | 5.15 | 1.92 | 141.07/105.28 | -7.80 | Neutral |
| Thermo Fisher Scientific | 501.59 | -0.64 | 191.01 | 21.90 | 22.87 | 0.30 | 643.99/385.72 | -19.04 | Very Bearish |
| Intuitive Surgical | 493.30 | 1.54 | 174.74 | 55.20 | 8.93 | -- | 608.88/427.84 | -7.86 | Very Bearish |
| Boston Scientific | 76.26 | 2.05 | 154.38 | 38.80 | 2.70 | -- | 107.53/72.01 | -0.44 | Bearish |
Market news
- Dow Jones Industrial Average breaks 50,000 level for first timeFebruary 7, 2026 9:16 AM
- US stocks fall, as investors fret over Trump's Fed nominee, earnings, inflationJanuary 31, 2026 8:34 AM
- Dow ends lower after topsy-turvy week, as Intel's outlook weighs on market sentimentJanuary 24, 2026 8:43 AM
- Wall Street ends little changed before long weekendJanuary 17, 2026 7:58 AM
About the company
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being through early detection and treatment. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment offers a range of diagnostics products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a portfolio of solutions for breast cancer care for radiology, pathology and surgery. The GYN Surgical segment offers a range of products, including its NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System as well as its Fluent Fluid Management system. The Skeletal Health segment offers products such as the Horizon DXA, a dual energy x-ray system, which evaluates bone density and performs body composition assessments, and the Fluoroscan Insight FD mini C-arm.